Publication Cover
Redox Report
Communications in Free Radical Research
Volume 1, 1994 - Issue 1
2
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Formation of reactive oxygen species during one-electron reduction of noradrenochrome catalyzed by NADPH-cytochrome P-450 reductase

&
Pages 65-70 | Published online: 13 Jul 2016

References

  • Hawley M D, Tatawawadi S V, Piekarski S, Adams R N. Electrochemical studies of the oxidation pathways of catecholamines. J Am Chem Soc 1967; 89: 447–450.
  • Harrison W H, Whisler W W, Hill B J. Catecholamine oxidation and ionization properties indicated from the H− release, tritium exchange, and spectral changes which occur during ferricyanide oxidation. Biochemistry 1968; 7: 3089–3093.
  • Graham D G. Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol Pharmacol 1978; 14: 633–643.
  • Segura-Aguilar J, Lind C. On the mechanism of the Mn3+-induced neurotoxicity of dopamine prevention of quinone-derived oxygen toxicity by DT-diaphorase and superoxide dismutase. Chem Biol Interact 1989; 72: 309–324.
  • Linderson Y, Baez S, Segura-Aguilar J. The protective effect of superoxide dismutase and catalase against formation of reactive oxygen species during reduction of cyclized norepinephrine orthoquinone by DT-diaphorase. Biochim Biophys Acta 1994; 1200: 197–204.
  • Baez S, Linderson Y, and Segura-Aguilar J. Superoxide dismutasae and catalase prevent the formation of reactive oxygen species during reduction of cyclized dopa ortho-quinone by DT-diaphorase. Chem Biol Interact 1994 (in press).
  • Hochstein P, Cohen G. The inhibitory effects of quinones and dihydric phenols on glucose metabolism in sub-cellular system of brain. J Neurochem 1960; 5: 370–378.
  • Heacock R A. The chemistry of adrenochrome and related compounds. Chem Rev 1959; 59: 181–237.
  • Bachur N R, Gordon S L, Gee M V, Kon H. NADPH cytochrome P-450 reductase activation of quinone anticancer agents to free radicals. Proc Natl Acad Sci USA 1979; 76: 954–957.
  • Shinha B K, Chignell C F. Binding mode of chemically activated semiquinone free radicals from quinone anticancer agents to DNA. Chem Biol Interact 1979; 28: 301–308.
  • Bindoli A, Rigobello M P, Deeble D J. Biochemical and toxicological properties of the oxidation products of catecholamines. Free Radic Biol Med 1992; 13: 391–405.
  • Fahn S, Cohen G. The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann Neurol 1992; 32: 804–812.
  • Graham D G. Catecholamine toxicity: a proposal for the molecular pathogenesis of manganese neurotoxicity and Parkinson's disease. Neurotoxicol 1984; 5: 83–96.
  • Yasukochi Y, Masters B S S. Some properties of a detergent-solubilized NADPH-cytochrome c (cytochrome P-450) reductase purified by biospecific affinity chromatography. J Biol Chem 1976; 251: 5337–5344.
  • Archibald F S, Fridovich I. The scavenging of superoxide radicals by manganous complex: in vitro. Arch Biochem Biophys 1982; 214: 452–463.
  • Bradford M M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248–254.
  • Graham D G, Tiffany S M, Bell W R, Gutknecht W F. Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine and related compounds towards Cl300 neuroblastoma cells in vitro. Mol Pharmacol 1978; 14: 644–653.
  • Halliwell B, Gutteridge J M C. Free radicals in biology and medicine. 1988: 76–77.
  • Prabhakaran K. Dopa metabolism by Mycobacterium leprae; its implications in culture of the bacillus and chemotheraphy of leprosy. Lepr Rev 1973; 44: 112–199.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.